Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
J Travel Med. 2010 Jul-Aug;17(4):233-42. doi: 10.1111/j.1708-8305.2010.00424.x.
Transmission of tuberculosis (TB) during travel is a significant potential infectious disease threat to travelers. However, there is uncertainty in the travel medicine community regarding the evidence base for both estimates of risk for latent TB infection (LTBI) in long-term travelers and for information regarding which travelers may benefit from pre- or post-travel TB screening. The purpose of this study was to determine the risk for tuberculin skin test (TST) conversion, used as a surrogate for LTBI, in long-term travelers from low- to high-risk countries.
We performed a systematic review to acquire all published and unpublished data on TST conversion in long-term civilian and military travelers from 1990 to June 2008. Point estimates and confidence intervals (CIs) of the incidence of TST conversion were combined in a random effects model and assessed for heterogeneity.
The cumulative risk with CI for LTBI as measured by TST conversion was 2.0% (99% CI: 1.6%-2.4%). There was a marked heterogeneity (chi(2) heterogeneity statistic, p < 0.0001) which could not be explained by evaluable study characteristics. When stratifying by military and civilian studies, the cumulative risk estimate was 2.0% (99% CI: 1.6-2.4) for military and 2.3% (99% CI: 2.1-2.5) for civilian studies.
The overall cumulative incidence of 2.0% is what could be expected to occur among the local population in many developing-country settings, though TST conversion likely overestimates the risk of TB infection because of the low positive predictive value (PPV) of the TST in low-prevalence populations such as travelers. To maximize the PPV of a screening test for LTBI, a targeted testing strategy for long-term military and civilian travelers is recommended, based on exposures known to increase the risk of TB. Studies to better define higher risk groups, activities, and locations are needed.
在旅行过程中传播结核病(TB)是旅行者面临的重大潜在传染病威胁。然而,旅行医学领域对于长期旅行者中潜伏性结核感染(LTBI)风险的评估依据以及哪些旅行者可能受益于旅行前或旅行后 TB 筛查存在不确定性。本研究的目的是确定来自低风险至高风险国家的长期旅行者中结核菌素皮肤试验(TST)转化的风险,该试验可作为 LTBI 的替代指标。
我们进行了系统评价,以获取 1990 年至 2008 年 6 月期间有关长期平民和军事旅行者 TST 转化的所有已发表和未发表的数据。点估计值和置信区间(CI)的 TST 转化发生率合并于随机效应模型中,并评估其异质性。
通过 TST 转化测量的 LTBI 的累积风险为 2.0%(99%CI:1.6%-2.4%)。存在明显的异质性(chi(2)异质性统计量,p<0.0001),无法用可评估的研究特征来解释。按军事和民用研究分层时,军事研究的累积风险估计值为 2.0%(99%CI:1.6-2.4),民用研究为 2.3%(99%CI:2.1-2.5)。
2.0%的总体累积发生率是在许多发展中国家的当地人群中可能出现的情况,尽管 TST 转化可能高估了 TB 感染的风险,因为 TST 在旅行者等低流行人群中的阳性预测值(PPV)较低。为了提高 LTBI 筛查试验的 PPV,建议针对长期军事和民用旅行者制定基于已知增加 TB 风险的暴露因素的靶向测试策略。需要开展研究以更好地确定更高风险的人群、活动和地点。